These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6732678)

  • 1. Experimental assessment of selected antimotion drugs.
    Matsnev EI; Bodo D
    Aviat Space Environ Med; 1984 Apr; 55(4):281-6. PubMed ID: 6732678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of experimental motion sickness on postrotatory nystagmus and the illusion of counterrotation].
    Aĭzikov GS; Kliushnikova ON
    Kosm Biol Aviakosm Med; 1985; 19(2):89-91. PubMed ID: 3990240
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of a vincamine derivative on vegetative reactions provoked by labyrinth stimulation.
    Bodó G; Hartmann J
    Ther Hung; 1979; 27(4):182-4. PubMed ID: 538749
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effectiveness of the preparation Gavinton in preventing motion sickness].
    Bodo D; Kotovskaia AR; Galle RR; Gavrilova LN; Gusakova GA
    Kosm Biol Aviakosm Med; 1982; 16(3):49-51. PubMed ID: 7098411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of antimotion sickness drug side effects on performance.
    Wood CD; Manno JE; Manno BR; Redetzki HM; Wood MJ; Mims ME
    Aviat Space Environ Med; 1985 Apr; 56(4):310-6. PubMed ID: 3888169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histaminergic response to Coriolis stimulation: implication for transdermal scopolamine therapy of motion sickness.
    Wang ET; Zhou DR; He LH
    Aviat Space Environ Med; 1992 Jul; 63(7):579-82. PubMed ID: 1616432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of histaminergic drugs in experimental motion sickness.
    Matsnev EI; Sigaleva EE
    J Vestib Res; 2007; 17(5-6):313-21. PubMed ID: 18626141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motion sickness in cats: a symptom rating scale used in laboratory and flight tests.
    Suri KB; Crampton GH; Daunton NG
    Aviat Space Environ Med; 1979 Jun; 50(6):614-8. PubMed ID: 475712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of severe motion sickness with antimotion sickness drug injections.
    Graybiel A; Lackner JR
    Aviat Space Environ Med; 1987 Aug; 58(8):773-6. PubMed ID: 3632537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of drugs in altering susceptibility to motion sickness in aerobatics and the slow rotation room.
    Deane FR; Wood CD; Graybiel A
    Aerosp Med; 1967 Aug; 38(8):842-5. PubMed ID: 6049246
    [No Abstract]   [Full Text] [Related]  

  • 11. Human centrifuge studies on the relative effectiveness of some antimotion sickness drugs.
    Wood CD; Graybiel A; McDonough R
    Aerosp Med; 1966 Feb; 37(2):187-90. PubMed ID: 5906041
    [No Abstract]   [Full Text] [Related]  

  • 12. Antimotion-sickness efficacy of scopolamine 12 and 72 hours after transdermal administration.
    Graybiel A; Cramer DB; Wood CD
    Aviat Space Environ Med; 1982 Aug; 53(8):770-2. PubMed ID: 7181807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Physiological reactions in motion sickness].
    Usachev VV
    Voen Med Zh; 1973 Aug; (8):56-61. PubMed ID: 4805201
    [No Abstract]   [Full Text] [Related]  

  • 14. Carbonic anhydrase inhibitors for prevention of space motion sickness: an avenue of investigation.
    Martin NF
    Aviat Space Environ Med; 1984 Dec; 55(12):1148-50. PubMed ID: 6517821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the efficacy of cinnarizine with scopolamine in the treatment of seasickness.
    Pingree BJ; Pethybridge RJ
    Aviat Space Environ Med; 1994 Jul; 65(7):597-605. PubMed ID: 7945125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theory of antimotion sickness drug mechanisms.
    Wood CD; Graybiel A
    Aerosp Med; 1972 Mar; 43(3):249-52. PubMed ID: 4402925
    [No Abstract]   [Full Text] [Related]  

  • 17. Motion sickness.
    Shupak A
    Aviat Space Environ Med; 1995 Apr; 66(4):385-6. PubMed ID: 7794234
    [No Abstract]   [Full Text] [Related]  

  • 18. INM investigations into drugs for seasickness prophylaxis.
    Pingree BJ
    J R Nav Med Serv; 1994; 80(2):76-80. PubMed ID: 7707278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone mimicks the antimotion sickness effects of amphetamine and scopolamine.
    Kohl RL
    Acta Astronaut; 1986 Sep; 13(9):565-71. PubMed ID: 11538662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of effectiveness of some antimotion sickness drugs using recommended and larger than recommended doses as tested in the slow rotation room.
    Wood CD; Graybiel A; Kennedy RS
    Aerosp Med; 1966 Mar; 37(3):259-62. PubMed ID: 5907763
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.